Caplight Logo









BrainTrip

BrainTrip

Private
NaxxarHealthcare & Life Scienceshttps://braintrip.net/

Last Round

VC Round

May 1, 2021

Total Funding Raised

$110,000

Company Overview

BrainTrip is a health-care company that has developed an AI-powered, EEG-based technology designed for fast, affordable, and non-invasive brain diagnostics to enable the early detection of cognitive decline.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

EEG analysiscognitive decline detectionmedical AIdementia detectionbrain health screeningneurotechpoint of care diagnosticsEEG biomarkershealthtechdigital biomarkersbrainwave analysismedical deviceclinical trial supportbrain age estimation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BrainTrip Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BrainTrip Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 1, 2021
AcceleratorMar 1, 2020
AcceleratorOct 17, 2019

Key People

Founding team and executive leadership

Jurij Dreo

Founder & CTO

Founding Team

David Sakić

Chief Executive Officer

Executive Team

BrainTrip Investors

Notable investors and investment history

InvestorRounds
Horizon 2020VC Round
RockstartAccelerator, VC Round
Fast Track MalmoAccelerator, VC Round
Impact VenturesVC Round
Skåne VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 17, 2025

    Grew 27% QoQ from 11 to 14 employees.

  • Jun 4, 2025

    Grew 30% QoQ from 10 to 13 employees.

BrainTrip Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BrainTrip Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BrainTrip's valuation, stock price, and market status.

Firmographic Details

HeadquartersNaxxar
Employee Range12
Year Founded2019
Last FundingMay 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.